Report for: Clonazepam for neuropathic pain and fibromyalgia in adults

Title	Clonazepam for neuropathic pain and fibromyalgia in adults
Published in	Cochrane database of systematic reviews, May 2012
DOI	10.1002/14651858.cd009486.pub2
Pubmed ID	22592742
Authors	Ruth Corrigan, Sheena Derry, Philip J Wiffen, R Andrew Moore
Abstract	Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Clonazepam, a benzodiazepine, is an established antiepileptic drug, but its place in the treatment of neuropathic pain is unclear.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United Kingdom	6	30%
Canada	2	10%
Colombia	1	5%
Germany	1	5%
Australia	1	5%
Spain	1	5%
France	1	5%
United States	1	5%
Sweden	1	5%
Other	0	0%
Unknown	5	25%

Demographic breakdown

Type	Count	As %
Members of the public	16	80%
Practitioners (doctors, other healthcare professionals)	2	10%
Scientists	2	10%

Mendeley readers

The data shown below were compiled from readership statistics for 154 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United Kingdom	2	1%
Germany	2	1%
Spain	1	<1%
Australia	1	<1%
Unknown	148	96%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	29	19%
Student > Bachelor	20	13%
Researcher	15	10%
Student > Postgraduate	15	10%
Student > Doctoral Student	11	7%
Other	30	19%
Unknown	34	22%

Readers by discipline	Count	As %
Medicine and Dentistry	71	46%
Nursing and Health Professions	13	8%
Neuroscience	7	5%
Psychology	6	4%
Pharmacology, Toxicology and Pharmaceutical Science	5	3%
Other	13	8%
Unknown	39	25%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2022.

All research outputs

#1,828,166

of 23,400,864 outputs

Outputs from Cochrane database of systematic reviews

#4,131

of 12,685 outputs

Outputs of similar age

#11,335

of 165,208 outputs

Outputs of similar age from Cochrane database of systematic reviews

#46

of 189 outputs

Altmetric has tracked 23,400,864 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,685 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.0. This one has gotten more attention than average, scoring higher than 67% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,208 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.

We're also able to compare this research output to 189 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.

Cochrane Database of Systematic Reviews

Clonazepam for neuropathic pain and fibromyalgia in adults

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context